Concepedia

Publication | Closed Access

Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.

29

Citations

0

References

2003

Year

Abstract

Using these doses and schedules, the GO regimen appears a safe therapy for patients with advanced urothelial cancer. Phase II studies are required to assess the possible role of this combination in advanced urothelial cancer.